Upregulation of urokinase receptor expression on migrating endothelial cells

Journal of Cell Biology

Volumn 122, Issue 3, 1993, Pages 673-684

  Pepper, M S ^a   Sappino, A P ^a   Stocklin R ^a   Montesano, R ^a   Orci, L ^a   Vassalli, J D ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL SURFACE RECEPTOR; PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL MIGRATION; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR UPREGULATION; WOUND;

ANIMAL; ANTIBODIES; BINDING SITES; CATTLE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; IN SITU HYBRIDIZATION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0027183188     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.122.3.673     Document Type: Article

References (67)

1. Appella, E., E. A. Robinson, S. J. Ullrich, M. P. Stoppelli, A. Corti, G. Cassani, and F. Blasi. 1987. The receptor-binding sequence of urokinase. J. Biol. Chem. 262:4437-4440.
2. Bacharach, E., A. Itin, and E. Keshet. 1992. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Natl. Acad. Sci. USA. 89:10686-10690.
3. Barnathan, E. S., A. Kuo, K. Karikó, L. Rosenfeld, S. Murray, N. Behrendt, E. Ronne, D. Weiner, J. Henkin, and D. B. Cines. 1990a. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood. 76:1795-1860.
4. Barnathan, E. S., A. Kuo, L. Rosenfeld, K. Karikó, M. Leski, F. Robbiati, M. L. Nolli, J. Henkin, and D. B. Cines. 1990b. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. J. Biol. Chem. 265:2865-2872.
5. Bauer, P. I., R. Machovich, K. G. Büki, E. Csonka, S. A. Koch, and I. Horváth. 1984. Interaction of plasmin with endothelial cells. Biochem. J. 218:119-124.
6. Belin, D., J.-D. Vassalli, C. Combépine, F. Godeau, Y. Nagamine, E. Reich, H. P. Kocher, and R. M. Duvoisin. 1985. Cloning, nucleotide sequencing and expression of cDNA's encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem. 148:225-232.
7. Behrendt, N., M. Plough, L. Patthy, G. Houen, F. Blasi, and K. Danø. 1991. The ligand binding domain of the cell surface receptor for urokinase plasminogen activator. J. Biol. Chem. 266:7842-7847.
8. 2 terminal amino acid sequence and glycosylation variants. J. Biol. Chem. 265:6453-6460.
9. Blasi, F. 1993. Urokinase and urokinase receptor: a paracrine/autorine system regulating cell migration and invasiveness. BioEssays. 15:105-111.
10. Blasi, F., J.-D. Vassalli, and K. Danø. 1987. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol. 104:801-804.
11. Bürk, R. R. 1973. A factor from a transformed cell line that affects cell migration. Proc. Natl. Acad. Sci. USA. 70:369-372.
12. Busso, N., D. Belin. C. Failly-Crépin, and J.-D. Vassalli. 1986. Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). J. Biol. Chem. 261:9309-9315.
13. D'Amore, P. A., and R. W. Thompson. 1987. Mechanisms of angiogenesis. Ann. Rev. Physiol. 49:453-464.
14. Del Rosso, M., G. Fibbi, G. Dini, C. Grappone, M. Pucci, R. Caldini, L. Magnelli, M. Fimiani, T. Lotti, and E. Panconesi. 1990. Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes. J. Invest. Dermatol. 94:310-316.
15. Dennis, P. A., and D. B. Rifkin. 1990. Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth. J. Cell Physiol. 144:84-98.
16. Estreicher, A., J. Mühlhauser, J.-L. Carpentier, L. Orci, and J.-D. Vassalli. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J. Cell Biol. 111: 783-792.
17. Fibbi, G., L. Magnelli, M. Pucci, and M. Del Rosso. 1990. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator. Exp. Cell Res. 187:33-38.
18. Fibbi, G., M. Ziche, L. Morbidelli, L. Magnelli, and M. Del Rosso. 1988. Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res 179:385-395.
19. Fisher, R., E. K. Waller, G. Grossi, D. Thompson, R. Tizard, and W. Schleuning. 1985. Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5′ flanking region. J. Biol. Chem. 260:11223-11230.
20. Furie, M. B., E. B. Cramer, B. L. Naprstek, and S. C. Silverstein. 1984. Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current. J. Cell Biol. 98:1033-1041.
21. Gajdusek, C. M., and S. Carbon. 1989. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J. Cell Physiol. 139: 570-579.
22. Gajdusek, C. M., and S. M. Schwartz. 1983. Technique for cloning bovine aortic endothelial cells. In Vitro. 19:394-402.
23. Glisin, V., R. Crkvenjakov, and C. Byus. 1974. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry. 13:2633-2637.
24. Grøndahl-Hansen, J., L. T. Kirkeby, E. Ralfkiaer, P. Kristensen, L. R. Lund, and K. Danø. 1989. Ulrokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix. Am. J. Pathol. 135: 631-636.
25. Gudewicz, P. W., and N. Gilboa. 1987. Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils. Biochem. Biophys. Res. Commun. 147:1176-1181.
26. Haddoch, R. C., M. L. Spell, C. D. Baker, R. Grammer, J. M. Parks, M. Speidel, and F. M. Booyse. 1991. Urokinase binding and receptor identification in cultured endothelial cells. J. Biol. Chem. 266:21466-21473.
27. Hajjar, K. A., P. C. Harpel, E. A. Jaffe, and R. L. Nachman. 1986. Binding of plasminogen to cultured human endothelial cells. J. Biol. Chem. 261: 11656-11662.
28. Krätzschmar, J., B. Haendler, S. Kojima, D. B. Rifkin, and W.-D. Schlenning. 1993. Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene. 125:177-183.
29. Kristensen, P., L.-I. Larsson, L. S. Nielsen, J. Grondahl-Hansen, P. A. Andreasen, and K. Danø. 1984. Human endothelial cells contain one type of plasminogen activator. FEBS (Fed. Eur. Biochem. Soc.) Lett. 168:33-37.
30. Larsson, L.-I., L Skriver, L. S. Nielsen, J. Grøndahl-Hansen, P. Kristensen, and K. Danø. 1984. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse, J. Cell Biol. 98:894-903.
31. Loskutoff, D. J., T. Ny, M. Sawdey, and D. Lawrence. 1986. Fibrinolytic system of cultured endothelial cells: Regulation by plasminogen activator inhibitor. J. Cell Biochem. 32:273-280.
32. McNeil, P. L., L. Muthukrishman, E. Warder, and P. A. D'Amore. 1989. Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 109:811-822.
33. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
34. Mignatti, P., R. Mazzieri, and D. B. Rifkin. 1991. Expression of urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 113:1193-1202.
35. Miles, L. A., E. G. Levin, J. Plescia, D. Collen, and E. F. Plow. 1988. Plasminogen receptors, urokinase receptors, and their modulation on human endothelial cells. Blood. 72:628-635.
36. Montesano, R., J.-D. Vassalli, A. Baird, R. Guillemin, and L. Orci. 1986. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA. 83:7297-7301.
37. Moscatelli, D. 1986. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J. Cell. Biochem. 30:19-29.
38. Moscatelli, D., M. Presta, and D. B. Rifkin. 1986. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production. DNA synthesis and migration. Proc. Natl. Acad. Sci. USA. 83:2091-2095.
39. Moscatelli, D., and D. B. Rifkin. 1988. Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim. Biophys. Acta. 948:67-85.
40. Muthukrishnan, L., E. Warder, and P. L. McNeil. 1991. Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell. Physiol. 148: 1-16.
41. Nusrat, A. R., and H. A. Chapman. 1991. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. J. Clin. Invest. 87:1091-1097.
42. Odekon, L. E., Y. Sato, and D. B. Rifkin. 1992. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell Physiol. 150:258-263.
43. Pepper, M. S., and R. Montesano. 1991. Proteolytic balance and capillary morphogenesis. Cell Diff. Dev. 32:319-328.
44. Pepper, M. S., and P. Meda. 1992. Basic fibroblast growth factor increases junctional communication and connexin43 expression in microvascular endothelial cells. J. Cell Physiol. 153:196-205.
45. Pepper, M. S., J.-D. Vassalli, R. Montesano, and L. Orci. 1987. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol. 105:2535-2541.
46. Pepper, M. S., D. Belin, R. Montesano, L. Orci, and J.-D. Vassalli. 1990. Transforming growth factor beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111:743-755.
47. Pepper, M. S., R. Montesano, L. Orci, and J.-D. Vassalli. 1991a. Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta. Biochem. Biophys. Res. Commun. 176:633-638.
48. Pepper, M. S., N. Ferrara, L. Orci, and R. Montesano. 1991b. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181:902-906.
49. Pepper, M. S., R. Montesano, A. El Aoumari, D. Gros, L. Orci, and P. Meda. 1992a. Coupling and connexin43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 262:C1246-C1257.
50. Pepper, M. S., A.-P. Sappino, R. Montesano, L. Orci, and J.-D. Vassalli. 1992b. Plasminogen activator inhibitor-1 is induced in migrating endothelial cells. J. Cell Physiol. 153:129-139.
51. Plough, M., E. Ronne, N. Behrendt, A. L. Jensen, F. Blasi, and K. Danø. 1991. Cellular receptor for urokinase plasminogen activator. J. Biol. Chem. 266:1926-1933.
52. Rabbani, S. A., J. Desjardins, A. W. Bell, D. Banville, A. Mazar, J. Henkin, and D. Goltzman. 1990. An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem. Biophys. Res. Commun. 173:1058-1064.
53. Rabbani, S. A., A. Mazar, S. Bernier, M. Haq, I. Bolivar, J. Henkin, and D. Goltzman. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:14151-14156.
54. Reilly, C. F., and J. E. Hutzelmann. 1992. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution. J. Biol. Chem. 267:17128-17135.
55. Rijken, D. C., G. Wijngaards, and J. Welbergen. 1980. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb. Res. 18:815-830.
56. Roldan, A. L., M. V. Cubellis, M. T. Masucci, N. Behrendt, L. R. Lund, K. Danø, and F. Blasi. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface plasmin-dependent proteolysis. EMBO (Eur. Mol. Biol. Organ.) J. 9:467-474.
57. Saksela, O., and D. B. Rifkin. 1988. Cell associated plasminogen activation: regulation and physiological functions. Ann. Rev. Cell Biol. 4:93-126.
58. Sappino, A.-P., J. Huarte, D. Belin, and J.-D. Vassalli. 1989. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109: 2471-2479.
59. Sato, Y., and D. B. Rifkin. 1989. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture. J. Cell Biol. 109:309-315.
60. Sholley, M. M., M. A. Gimbrone, and R. S. Cotran. 1977. Cellular migration and replication in endothelial regeneration. A study using irradiated endothelial cultures. Lab. Invest. 36:18-25.
61. Stoppelli, M. P., A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R. K. Assoian. 1985. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA. 82:4939-4943.
62. Thomas, P. S. 1980. Hybridization of RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA. 77:5201-5205.
63. r 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100:86-92.
64. Vassalli, J.-D., and D. Belin. 1987. Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS (Fed. Eur. Biochem. Soc.) Lett. 214:187-191.
65. Vassalli, J.-D., J.-M. Dayer, A. Wohlwend, and D. Belin. 1984. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Med. 159:1653-1668.
66. Vassalli, J.-D., A.-P. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
67. Zetter, B. R. 1988. Angiogenesis. State of the art. Chest. 93:159S-166S.